Clincosm LogoSign in Get a demo

chronic inflammatory demyelinating polyneuropathy

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RWE-based Treatment Patterns and Outcomes in CIDP

Not yet recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • +2 more
  • No intervention. Retrospective observation only.
  • Salford, United Kingdom
    Northern Care Alliance NHS Foundation Trust
Jul 7, 2023

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
  • +2 more
  • Boca Raton, Florida
  • +1 more
Jan 31, 2023

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)

No longer available
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • HB-adMSCs
  • Sugar Land, Texas
    Hope Biosciences Stem Cell Research Foundation
Sep 20, 2022

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • VitalStim 400
  • VitalStim400
  • Atlanta, Georgia
    Center for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

Suspended
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Hizentra
  • Angers, France
  • +16 more
Mar 4, 2022

Clinical and Electrophysiological Patterns of Chronic Dysimmune

Not yet recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
    • (no location specified)
    Jan 20, 2022

    A Registered Cohort Study of Immune-Mediated Neuropathies

    Recruiting
    • Chronic Inflammatory Demyelinating Polyneuropathy
      • Beijing, Beijing, China
      • +1 more
      Dec 28, 2021

      Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)

      Withdrawn
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • (no location specified)
      Nov 2, 2021

      Chronic Inflammatory Demyelinating Polyneuropathy Trial in Tampa (Immune Globulin Subcutaneous (Human))

      Completed
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Immune Globulin Subcutaneous (Human)
      • Tampa, Florida
        USF Dept of Neurology
      Sep 14, 2021

      NT-3 Levels and Function in Individuals With CMT

      Recruiting
      • Charcot-Marie-Tooth Disease
      • +2 more
      • NT3 blood draw
      • Columbus, Ohio
        Nationwide Children's Hospital
      Aug 17, 2021

      Telemonitoring System in the Management of Patients With CIDP

      Terminated
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • HOME LINK
      • Bordeaux, France
      • +9 more
      Jan 13, 2021

      Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Charcot-Marie-Tooth Disease Trial in Creteil (MD1003)

      Completed
      Has Results
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • +5 more
      • Creteil, France
        Hôpital Henri Mondor, Créteil, France
      Oct 29, 2020

      CIDP, Chronic Inflammatory Demyelinating Polyneuropathy Trial in Portland (lipoic acid)

      Completed
      Has Results
      • CIDP
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • lipoic acid
      • Portland, Oregon
        Oregon Health & Science University
      Aug 18, 2020

      Fluctuations in CIDP Patients Using Daily Grip Strength

      Completed
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Intravenous Immunoglobulin
      • Johns Creek, Georgia
      • +6 more
      Aug 12, 2020

      Chronic Inflammatory Demyelinating Polyneuropathy Trial in Chicago (hematopoietic stem cell transplantation)

      Completed
      Has Results
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • hematopoietic stem cell transplantation
      • Chicago, Illinois
        Northwestern University, Feinberg School of Medicine
      Jul 15, 2020

      Decreased Corneal Sensation in Chronic Inflammatory

      Completed
      • Chronic Inflammatory Demyelinating Polyneuropathy
        • Buffalo, New York
          Dent Neurological Institute
        Jun 21, 2019

        Chronic Inflammatory Demyelinating Polyneuropathy, Polyradiculoneuropathy Trial in Worldwide (IgPro20 (low dose), Placebo,

        Completed
        Has Results
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • Polyradiculoneuropathy
        • IgPro20 (low dose)
        • +3 more
        • Birmingham, Alabama
        • +90 more
        Jul 3, 2018

        Chronic Inflammatory Demyelinating Polyneuropathy, Charcot-Marie-Tooth Disease, Type IA, Anti-MAG Neuropathy Trial in Nantes

        Unknown status
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • +2 more
        • elastography measurements
        • Nantes, France
          Univeristy of Nantes
        Mar 1, 2018

        Peripheral Neuropathy, Diabetes, Chronic Inflammatory Demyelinating Polyneuropathy Trial in Toronto (10% intravenous

        Unknown status
        • Peripheral Neuropathy
        • +2 more
        • 10% intravenous immunoglobulin (IVIg)
        • 0.9% sodium chloride
        • Toronto, Ontario, Canada
          Toronto General Hospital / Toronto Western Hospital
        Nov 10, 2016

        Chronic Inflammatory Demyelinating Polyneuropathy Trial in United States (H.P. Acthar® Gel)

        Withdrawn
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • H.P. Acthar® Gel
        • Phoenix, Arizona
        • +4 more
        Jul 15, 2016

        Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy Trial in Aarhus C, Copenhagen (Resistance

        Completed
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • Multifocal Motor Neuropathy
        • Resistance training
        • Aerobic training
        • Aarhus C, Denmark
        • +1 more
        May 11, 2016

        Chronic Inflammatory Demyelinating Polyneuropathy Trial in Osaka (NPB-01)

        Completed
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • Osaka, Japan
          Nihon Pharmaceutical Co., Ltd
        Jan 17, 2016

        Immunoglobulin Dosage and Administration Form in CIDP and MMN

        Completed
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • +2 more
        • Copenhagen, Denmark
          Department of Neurology, Rigshospitalet
        Sep 18, 2015